Osteogenesis imperfecta - Clinical outcomes after a 4-year experience with cyclical intravenous pamidronate therapy

被引:1
|
作者
Castro, L. C. [1 ]
Santos, C. C. [1 ]
Campos, M. L. [1 ]
Gameleira, K. P. [1 ]
Rorato, M. G. [1 ]
Bezerra, A. C. [1 ]
Cruz, C. B. [1 ]
机构
[1] Univ Brasilia, Dept Pediat, Brasilia, DF, Brazil
关键词
D O I
10.1016/j.bone.2009.04.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S59 / S59
页数:1
相关论文
共 50 条
  • [1] Effects of cyclical intravenous pamidronate therapy on bone markers in pediatric patients with osteogenesis imperfecta
    Campos, Moema L.
    Rorato, Marilia G.
    Gameleira, Kallianna P.
    Vilaca, Renata D.
    Bezerra, Ana Cristina A.
    Cruz, Catia B.
    Castro, Luiz Claudio G.
    HORMONE RESEARCH, 2009, 72 : 80 - 80
  • [2] The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta Type V
    Zeitlin, L
    Rauch, F
    Travers, R
    Munns, C
    Glorieux, FH
    BONE, 2006, 38 (01) : 13 - 20
  • [3] Osteogenesis imperfecta: Continuous increment of bone mass with cyclical intravenous pamidronate following oral therapy.
    Tau, C
    Mautelen, C
    Brunetto, O
    Alvarez, V
    Rubinstein, M
    BONE, 2002, 30 (06) : 942 - 942
  • [4] Osteogenesis imperfecta type VI in childhood and adolescence: Effects of cyclical intravenous pamidronate treatment
    Land, Christof
    Rauch, Frank
    Travers, Rose
    Glorieux, Francis H.
    BONE, 2007, 40 (03) : 638 - 644
  • [5] Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta
    Land, C
    Rauch, F
    Glorieux, FH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (03) : 374 - 379
  • [6] Osteogenesis imperfecta: continuous increment of bone mass with two years of cyclical intravenous pamidronate following oral therapy
    Tau, C
    Mautalen, C
    Brunetto, O
    Alvarez, V
    Farenga, M
    Rubinstein, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S370 - S370
  • [7] Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta
    Lowing, Kristina
    Astrom, Eva
    Oscarsson, Katarina Allbrink
    Soderhall, Stefan
    Eliasson, Ann-Christin
    ACTA PAEDIATRICA, 2007, 96 (08) : 1180 - 1183
  • [8] Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
    Land, C.
    Rauch, E.
    Travers, R.
    Glorieux, F.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S119 - S119
  • [9] Pamidronate in osteogenesis imperfecta: Evaluation after 5 year of treatment
    Sales, Marques J.
    Garrido, A.
    Moreira, D.
    Campos, Costa R.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 143 - 143
  • [10] Effect of cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label study in seven patients
    Giraud, F
    Meunier, PJ
    JOINT BONE SPINE, 2002, 69 (05) : 486 - 490